JPRN-UMIN000016706已完成未知
Efficacy and safety of inhaled N-acetylcysteine in idiopathic pulmonary fibrosis - Efficacy of inhaled N-acetylcysteine in IPF
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion of other clinically known causes of UIP such as drug-induced pneumonitis, collagen vascular diseases, and hypersensitivity pneumonitis.
研究者
相似试验
进行中（未招募）
不适用
The effect of inhaled N-Acetylcysteine compared to normal saline on sputum rheology and lung functioCystic FibrosisEUCTR2008-008317-20-BEniversity Hospital Ghent
尚未招募
2 期
A clinical trial to study safety and efficacy of N-Acetylcysteine (NAC)(new drug) as an adjunct to standard treatment in patients with acute ischemic strokeCTRI/2019/05/019305AIIMS New Delhi
尚未招募
3 期
The effect of N-Acetylcysteine on COVID-19IRCT20200509047364N3Bandare-abbas University of Medical Sciences40
招募中
2 期
Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)IRCT20090808002306N7Esfahan University of Medical Sciences45
尚未招募
3 期
‘Effectiveness and safety of the use of N-acetylcysteine in patients with kidney failure in leptospirosis’SLCTR/2018/016ational Research Council of Sri Lanka